| P50 | author | Karen King | Q88956381 |
| P2093 | author name string | Alan Macken | |
| | Clodagh S O'Gorman | |
| | Ophelia Blake | |
| P2860 | cites work | Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia | Q44834771 |
| | Trends in risk factors for cardiovascular disease among children and adolescents in the United States | Q45170095 |
| | Hypercholesterolemia--a disease with expression from childhood. | Q45326595 |
| | Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy | Q46408437 |
| | Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia | Q46685612 |
| | Early left ventricular abnormalities in children with heterozygous familial hypercholesterolemia | Q47309705 |
| | Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. | Q51020618 |
| | Changes in the textural characteristics of intima-media complex in young patients with familial hypercholesterolemia: implication for visual inspection on B-mode ultrasound. | Q52608109 |
| | Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. | Q53892360 |
| | Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. | Q55034145 |
| | Familial hypercholesterolaemia: summary of NICE guidance | Q57316582 |
| | Distribution of Lipoproteins by Age and Gender in Adolescents | Q57717570 |
| | Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group | Q68607832 |
| | Prevalence of high cholesterol, high blood pressure, and smoking among elementary schoolchildren in North Carolina | Q73739037 |
| | Atherosclerosis--a pediatric nutrition problem? | Q78886016 |
| | Summary of the American Heart Association's scientific statement on drug therapy of high-risk lipid abnormalities in children and adolescents | Q80178272 |
| | Storm over statins--the controversy surrounding pharmacologic treatment of children | Q82061154 |
| | Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia | Q84159263 |
| | Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association | Q22241920 |
| | Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report | Q22305957 |
| | Statins for children with familial hypercholesterolemia | Q24194816 |
| | The LDL receptor | Q24658039 |
| | Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents | Q27002669 |
| | Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial | Q28273112 |
| | Simvastatin with or without ezetimibe in familial hypercholesterolemia | Q28274454 |
| | Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 |
| | Atherosclerotic cardiovascular disease beginning in childhood | Q33616223 |
| | Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial | Q34222023 |
| | Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study | Q34470547 |
| | Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefits | Q34566253 |
| | Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 |
| | A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia | Q34637705 |
| | An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia | Q34700305 |
| | Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study | Q34757807 |
| | The use of statins in pediatrics: knowledge base, limitations, and future directions | Q36726032 |
| | Mechanisms of disease: genetic causes of familial hypercholesterolemia | Q36767518 |
| | Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force | Q36868062 |
| | Lipid screening and cardiovascular health in childhood | Q37205462 |
| | Evaluation of AAP guidelines for cholesterol screening in youth: Project HeartBeat! | Q37344889 |
| | Spectrum and management of hypertriglyceridemia among children in clinical practice | Q37378251 |
| | Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability | Q37892524 |
| | Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. | Q37901641 |
| | A review of guidelines for dyslipidemia in children and adolescents | Q38077792 |
| | Impact of dietary and exercise interventions on weight change and metabolic outcomes in obese children and adolescents: a systematic review and meta-analysis of randomized trials | Q38115437 |
| | Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum | Q38196511 |
| | Implementation of lipid screening guidelines in children by primary pediatric providers | Q39311827 |
| | Universal versus targeted blood cholesterol screening among youth: The CARDIAC project | Q39857902 |
| | Early statin therapy restores endothelial function in children with familial hypercholesterolemia | Q40613252 |
| | Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment | Q42228228 |
| | Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study | Q43815696 |
| | NHLBI Integrated Guidelines on Cardiovascular Disease Risk Reduction: can we clarify the controversy about cholesterol screening and treatment in childhood? | Q44334791 |
| | Statin treatment in children with familial hypercholesterolemia: the younger, the better | Q44416450 |
| P433 | issue | 1 | |
| P304 | page(s) | 179-188 | |
| P577 | publication date | 2018-06-01 | |
| P1433 | published in | Irish Journal of Medical Science | Q6070885 |
| P1476 | title | Cholesterol screening and statin use in children: a literature review | |
| P478 | volume | 188 | |